TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
DTIL

Precision BioSciences Inc

Healthcare · Biotechnology

6.70$ +0.0% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement DTIL
Line item 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-7.6% +67.8% +104.3% +9.2% +375.7% -78.3% +94.1% +41.0% -50.1%
-8.3% -44.6% -39.9%
-7.6% +67.8% +104.3% +9.2% +375.7% -78.3% +94.1% +41.0% -50.1%
+123.3% +122.0% +82.7% +19.0% +17.5% -60.0% +15.7% +11.6% -9.0%
+30.0% +70.6% +97.7% +33.4% +10.0% +4.1% -5.3% -9.7% -8.7%
+86.4% +107.5% +86.1% +22.5% +15.5% -43.6% +5.8% +2.6% -8.9%
+351.6% -83.9% +741.7% +100.7% -20.1% -20.2%
-750.3%
-610.7% -97.0% +3,466.8% +141.7%
-738.0%
-413.7%

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?